Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,145 results that match your search.22,145 results
  • Argentina
  • The USPTO has introduced profound changes to the rules on claims and continuations. Brian Hannon, Miku Mehta, and John Bird of Sughrue Mion PLLC discuss the implications the rules will have for company practices and provide suggestions for how best to respond
  • Protecting the IP rights of one of the most valuable brands in the world is a daunting task. In few places is it more challenging than in Asia. Daniel Greif, trade mark counsel for Coca-Cola's Pacific Group, tells Emma Barraclough how he manages the company's regional portfolio of more than 5,000 trade marks
  • Malaysia's accession to the Patent Cooperation Treaty required legislative amendments to bring the country into line with international patent practice. Patrick Mirandah and Ramakrishna Damodharan of Patrick Mirandah Co analyze the new rules
  • Last year Russia overhauled its IP legislation. Managing IP hosted a roundtable in Moscow to discuss the changes
  • The Italian Council of Ministers has recently approved the bill ratifying the deed of revision of the European Patent Convention 2000 (EPC 2000). The bill is now being examined by the Italian Parliament and its approval is expected by the date that the Convention comes into force.
  • Jorge Amigo Castañeda, director-general of the Mexican Institute of Industrial Property, outlines the challenges the Institute faces, and the steps it is taking to improve life for IP owners in Mexico
  • The European Commission recently published figures for 2006 relating to seizures by national Customs authorities of goods infringing IP rights on their entry into the EU. These reveal a considerable increase in the number of counterfeit and pirated articles being seized generally, Customs seizing more than 250 million articles in 2006 compared with 75 million in 2005; but in particular highlight a rapid growth in the trade of counterfeit medicines.
  • Data exclusivity, a key IP concern for research-based pharmaceutical companies, was introduced into the Turkish legislation with the publication of the Regulation on Marketing Authorization for Medicinal Products for Human Use in January 2005. The regulation only relates to pharmaceuticals for human use and does not bring exclusivity on the test data relating to agricultural chemicals, such as pesticides or insecticide, to obtain authorization for marketing in the country.